Pharming Group N.V.PHARNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank46
3Y CAGR-25.1%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-25.1%/yr
Quarterly compound
Percentile
P46
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 4.36% |
| Q2 2025 | 17.86% |
| Q1 2025 | -14.65% |
| Q4 2024 | 23.81% |
| Q3 2024 | 1.11% |
| Q2 2024 | 33.18% |
| Q1 2024 | -31.56% |
| Q4 2023 | 21.84% |
| Q3 2023 | 21.43% |
| Q2 2023 | 29.04% |
| Q1 2023 | -16.60% |
| Q4 2022 | -7.84% |
| Q3 2022 | 10.38% |
| Q2 2022 | 7.57% |
| Q1 2022 | 1.90% |
| Q4 2021 | 0.00% |
| Q2 2021 | -2.25% |
| Q1 2021 | -37.97% |
| Q4 2020 | 20.01% |
| Q3 2020 | 29.28% |
| Q2 2020 | -16.73% |
| Q1 2020 | 0.00% |
| Q4 2019 | 17.29% |
| Q3 2019 | -5.51% |
| Q2 2019 | 24.01% |
| Q1 2019 | -2.03% |
| Q4 2018 | -11.19% |
| Q3 2018 | 40.34% |
| Q2 2018 | -10.89% |
| Q1 2018 | -11.15% |
| Q4 2017 | 29.66% |
| Q3 2017 | 70.23% |
| Q2 2017 | 12.19% |
| Q1 2017 | 137.90% |
| Q4 2016 | 78.86% |
| Q3 2016 | 15.65% |
| Q2 2016 | 33.80% |
| Q1 2016 | 9.47% |
| Q4 2015 | -37.62% |
| Q3 2015 | -6.83% |